Chi Zhao

Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Development of high-grade glioma as a second malignant neoplasm in patients treated for primary brain tumors.

Development of high-grade glioma as a second malignant neoplasm in patients treated for primary brain tumors.

Journal: Discover oncology

Published: December 02, 2025

Development of an integrated risk stratification model for metastatic medulloblastoma (M2/3) using clinical, radiologic, and molecular variables.

Development of an integrated risk stratification model for metastatic medulloblastoma (M2/3) using clinical, radiologic, and molecular variables.

Journal: Neuro-oncology advances

Published: June 16, 2025

Alterations of the tumor microenvironment (TME) by exploratory gene expression analysis in recurrent glioblastoma following apatinib in combination with temozolomide.

Alterations of the tumor microenvironment (TME) by exploratory gene expression analysis in recurrent glioblastoma following apatinib in combination with temozolomide.

Journal: Biochemistry and biophysics reports

Published: May 28, 2025

A novel perspective on dissemination: somatic metastasis of germ cell tumors from the central nervous system.

A novel perspective on dissemination: somatic metastasis of germ cell tumors from the central nervous system.

Journal: Discover oncology

Published: February 20, 2025

Multiplatform molecular analyses reveal two molecular subgroups of NF2-related schwannomatosis vestibular schwannomas with distinct tumour microenvironment and therapeutic vulnerabilities.

Multiplatform molecular analyses reveal two molecular subgroups of NF2-related schwannomatosis vestibular schwannomas with distinct tumour microenvironment and therapeutic vulnerabilities.

Journal: Acta neuropathologica

Published: November 05, 2024

Ganglioglioma with MAP2K1 Mutation and CDKN2A/B Homozygous Deletion: A Case Report.

Ganglioglioma with MAP2K1 Mutation and CDKN2A/B Homozygous Deletion: A Case Report.

Journal: British journal of hospital medicine (London, England : 2005)

Published: October 30, 2024

Correction: Apatinib combined with temozolomide in diffuse midline glioma: a novel and effective therapy.

Correction: Apatinib combined with temozolomide in diffuse midline glioma: a novel and effective therapy.

Journal: BMC cancer

Published: July 11, 2024

Apatinib combined with temozolomide in diffuse midline glioma: a novel and effective therapy.

Apatinib combined with temozolomide in diffuse midline glioma: a novel and effective therapy.

Journal: BMC cancer

Published: January 20, 2024

Loss of 5-Hydroxymethylcytosine as an Epigenetic Signature That Correlates With Poor Outcomes in Patients With Medulloblastoma.

Loss of 5-Hydroxymethylcytosine as an Epigenetic Signature That Correlates With Poor Outcomes in Patients With Medulloblastoma.

Journal: Frontiers in oncology

Published: September 07, 2020

Awake craniotomy for assisting placement of auditory brainstem implant in NF2 patients.

Awake craniotomy for assisting placement of auditory brainstem implant in NF2 patients.

Journal: Acta oto-laryngologica

Published: January 25, 2018

Prognostic value of Ki-67 index in adult medulloblastoma after accounting for molecular subgroup: a retrospective clinical and molecular analysis.

Prognostic value of Ki-67 index in adult medulloblastoma after accounting for molecular subgroup: a retrospective clinical and molecular analysis.

Journal: Journal of neuro-oncology

Published: November 20, 2017

Distinctive localization and MRI features correlate of molecular subgroups in adult medulloblastoma.

Distinctive localization and MRI features correlate of molecular subgroups in adult medulloblastoma.

Journal: Journal of neuro-oncology

Published: May 26, 2017

Showing 1-12 of 14

Last Updated: 09/26/2026